Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
NCT ID | NCT03950297 |
Title | Phase 1, First in Human, Open-Label, Dose-Escalation Study of 609A |
Recruitment | Unknown status |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
NEXT Oncology Business Office | RECRUITING | San Antonio | Texas | 78229 | United States | Details |